E-LIB Suche - Ergebnisse für: Kolyadina, I.

1

Прогностическая значимость генетического статуса ТОР2А в HE..:

Kolyadina, I. V ; Zavalishina, L. E ; Andreeva, Yu. Yu...
Уральский медицинский журнал. 2019. № 10(178).. , 2019

Link: http://elib.usma.ru/hand..

2

CHARACTERISTICS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN ..:

D. Morozov A ; I. Kolyadina V ; I. Ganshina P...
https://www.malignanttumors.org/jour/article/view/924/667. , 2022

Link: https://www.malignanttum..

3

Olaparib in the metastatic HER2-negative breast cancer sett..:

L. Zhukova G ; E. Khatkova I ; I. Ganshina P...
https://www.med-sovet.pro/jour/article/view/5930/5414. , 2020

Link: https://www.med-sovet.pr..

4

ASSOCIATION OF NKT- AND ACTIVATED CD25+ PERIPHERAL BLOOD LY..:

A. Chertkova I ; E. Slavina G ; T. Zabotina N...
https://www.siboncoj.ru/jour/article/view/1641/809. , 2020

Link: https://www.siboncoj.ru/..

5

Assessment of the receptor status in primary breast cancer ..:

O. Gordeeva O ; L. Zhukova G ; I. Kolyadina V...
https://www.siboncoj.ru/jour/article/view/1018/624. , 2019

Link: https://www.siboncoj.ru/..

6

Multiparametric ultrasound diagnosis of metastatic and lymp..:

E. Kovaleva V ; T. Danzanova Yu ; G. Sinyukova T...
https://www.malignanttumors.org/jour/article/view/583/403. , 2019

Link: https://www.malignanttum..

7

Ribociclib for the treatment of hormone-positive HER2-negat..:

I. Ganshina P ; D. Filonenko A ; O. Gordeeva O...
https://www.med-sovet.pro/jour/article/view/3055/2979. , 2019

Link: https://www.med-sovet.pr..

8

EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FE..:

E. Lubennikova V ; I. Ganshina P ; A. Lud N...
https://www.med-sovet.pro/jour/article/view/2165/2148. , 2017

Link: https://www.med-sovet.pr..

9

SURGICAL TRETMENT OF EARLY BREAST CANCER: WHAT HAS CHANGED?..:

I. Kolyadina V ; I. Poddubnaya V ; C. van de Velde J.H...
https://www.siboncoj.ru/jour/article/view/98/100. , 2016

Link: https://www.siboncoj.ru/..

10

The use of ribociclib in real clinical practice: results of..:

A. V. Sultanbaev ; I. V. Kolyadina ; Sh. I. Musin...
https://www.med-sovet.pro/jour/article/view/7982/7069. , 2024

Link: https://www.med-sovet.pr..

11

Clinical and morphological aspects of neoadjuvant chemother..:

D. A. Morozov ; I. V. Kolyadina ; I. V. Poddubnaya...
https://ojrs.abvpress.ru/ojrs/article/view/894. , 2022

Link: https://doi.org/10.17650..

12

Possibilities of mammography, ultrasound, and MRI in the di..:

G. S. Alieva ; G. P. Korzhenkova ; I. V. Kolyadina
https://ojrs.abvpress.ru/ojrs/article/view/774. , 2021

Link: https://doi.org/10.17650..

13

10 years of success achieved by eribulin while treating HER..:

I. V. Kolyadina
https://ojrs.abvpress.ru/ojrs/article/view/864. , 2021

Link: https://doi.org/10.17650..

14

Ribociclib in the treatment of HR+ HER2-negative metastatic..:

I. V. Kolyadina
https://ojrs.abvpress.ru/ojrs/article/view/845. , 2021

Link: https://doi.org/10.17650..

15

Key studies that have changed the history and treatment of ..:

I. V. Kolyadina ; I. V. Poddubnaya
https://ojrs.abvpress.ru/ojrs/article/view/766. , 2021

Link: https://doi.org/10.17650..